ORGS OTC
Orgenesis Inc.
1W: +16.0%
1M: +65.7%
3M: +45.0%
YTD: +286.7%
1Y: -26.6%
3Y: -90.7%
5Y: -98.8%
$0.58
+0.03 (+5.45%)
Weekly Expected Move ±739.3%
$-8
$-4
$1
$5
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
54 relationships54
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2022-04-25
Earliest Filing
2026-01-26
Latest Filing
partner: 25
customer: 11
target: 8
investor: 6
acquirer: 4
Counterparties (Filed by ORGS)
54 relationshipsCompanies named in ORGS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Orgenesis Inc. | ORGS | partner | Issuer of the non-transferable share purchase warrants | 2026-01-26 | View |
| Theracell Laboratories IKE | — | customer | Borrower receiving the loan and credit facility. | 2025-09-16 | View |
| Orgenesis Inc. | ORGS | partner | Parent company of the Borrower. | 2025-09-16 | View |
| Cellvira | — | partner | Subsidiary of the Parent Company whose assets may be transferred to the Lender. | 2025-09-16 | View |
| Tissue Genesis | — | partner | Subsidiary of the Parent Company whose assets may be transferred to the Lender. | 2025-09-16 | View |
| NewTech Investment Holdings, LLC | — | partner | Entity whose loan must be paid off prior to conversion. | 2025-09-16 | View |
| Ariel Malik | — | partner | Individual whose loan must be paid off prior to conversion. | 2025-09-16 | View |
| Williamsburg Venture Holdings, LLC | — | investor | Investor purchasing common stock | 2025-01-28 | View |
| Orgenesis Inc | ORGS | partner | Company issuing common stock | 2025-01-28 | View |
| Orgenesis Maryland, LLC | ORGS | customer | Borrower issuing $1M promissory note | 2024-08-26 | View |
| Orgenesis Inc. | ORGS | partner | Parent company of the Borrower and warrant issuer | 2024-08-26 | View |
| Orgenesis, Inc. | ORGS | partner | Biotech company entering a strategic partnership to develop and commercialize cell and gene therapies. | 2024-08-14 | View |
| Harley Street Healthcare Group (London) Plc Ltd. | — | partner | UK-based healthcare group partnering with Orgenesis to launch a joint venture for wellness and longevity services. | 2024-08-14 | View |
| Orgenesis Maryland LLC | ORGS | partner | Orgenesis subsidiary to provide exclusive cell therapy processing services | 2024-07-12 | View |
| Orgenesis, Inc. | ORGS | acquirer | Purchaser of assets and joint venture rights from Broaden | 2024-07-12 | View |
| Broaden Bioscience and Technology Corp | — | target | Seller of assets and joint venture rights to Orgenesis | 2024-07-12 | View |
| Orgenesis Inc. | ORGS | partner | Parent company of the Borrower | 2024-07-08 | View |
| Koligo Therapeutics INC. | — | customer | Borrower receiving $2M loan for working capital | 2024-07-08 | View |
| Orgenesis Inc. | ORGS | target | Company issuing shares to extinguish debt owed to Purchaser | 2024-05-23 | View |
| Koligo Therapeutics Inc. | — | partner | Wholly-owned subsidiary of Orgenesis Inc. owing debt | 2024-05-23 | View |
| Yehuda Nir | — | investor | Purchaser exchanging debt for common stock | 2024-05-23 | View |
| Orgenesis Maryland LLC | ORGS | target | Sold assets and licensed intellectual property to Griffin Fund 3 Bidco, Inc. | 2024-04-11 | View |
| Griffin Fund 3 Bidco, Inc. | — | acquirer | Acquired assets and entered into strategic collaboration with Orgenesis Maryland LLC | 2024-04-11 | View |
| Germfree Laboratories LLC | — | partner | Purchasing OMPUL assets and entering into strategic collaboration for manufacturing and leasing. | 2024-03-01 | View |
| Orgenesis | ORGS | partner | Selling OMPUL assets and providing technology transfer and manufacturing supply. | 2024-03-01 | View |
| Metalmark Management II LLC | — | partner | Advisory services provider whose agreement is being terminated | 2024-01-24 | View |
| Davis Polk & Wardwell | — | investor | Law firm whose legal expenses are to be paid by Target | 2024-01-24 | View |
| Orgenesis Maryland | ORGS | partner | Entity owing loans to the Seller, related to Orgenesis Inc. | 2024-01-24 | View |
| MM OS Holdings L.P. | — | target | Selling all equity interests in Octomera LLC | 2024-01-24 | View |
| Tissue Genesis International LLC | — | partner | Excluded asset entity whose revenues are excluded from royalty calculations | 2024-01-24 | View |
| Orgenesis Inc. | ORGS | acquirer | Purchasing MM OS Holdings L.P. interests in Octomera LLC | 2024-01-24 | View |
| Octomera LLC | — | target | Target company being acquired by Orgenesis Inc. | 2024-01-24 | View |
| Orgenesis Gmbh | ORGS | partner | Excluded asset entity whose revenues are excluded from royalty calculations | 2024-01-24 | View |
| Koligo Therapeutics, Inc. | — | customer | Received a convertible loan from Sai Traders and is a wholly-owned subsidiary of Orgenesis Inc. | 2023-10-05 | View |
| Orgenesis Inc. | ORGS | partner | Parent company of Koligo Therapeutics, Inc. | 2023-10-05 | View |
| MM OS Holdings, L.P. | — | investor | Investor making a $1,000,000 cash investment for Class A Preferred Units | 2023-07-07 | View |
| Morgenesis LLC | — | target | Target company receiving investment for business expansion | 2023-07-07 | View |
| Orgenesis Inc. | ORGS | partner | Parent company required to sign the amendment | 2023-07-07 | View |
| Morgenesis LLC | — | target | Target company receiving investment for business expansion | 2023-05-10 | View |
| MM OS Holdings, L.P. | — | investor | Investor making a $5,000,000 cash investment for Class A Preferred Units | 2023-05-10 | View |
| Orgenesis Inc. | ORGS | partner | Parent company of the target and signatory to the amendment | 2023-05-10 | View |
| Koligo Therapeutics Inc. | — | customer | Borrower receiving convertible loan financing for working capital and operations | 2023-03-31 | View |
| Orgenesis Inc. | ORGS | customer | Borrower in the convertible loan agreement | 2023-01-13 | View |
| Morgenesis LLC | — | target | Target company issuing Class A Preferred Units to Investor | 2022-11-07 | View |
| Orgenesis Inc. | ORGS | acquirer | Parent company of the target and recipient of Earnout Payments | 2022-11-07 | View |
| MM OS Holdings, L.P. | — | investor | Investor purchasing Class A Preferred Units and making future investments | 2022-11-07 | View |
| Perella Weinberg Partners LP | PWP | partner | Broker/finder receiving fees for the transaction | 2022-11-07 | View |
| BDO USA, LLP | — | partner | Accountants resolving disputes regarding investment calculations | 2022-11-07 | View |
| Morgenesis LLC | — | customer | Senior Secured Convertible Loan Agreement Borrower | 2022-08-17 | View |
| Orgenesis Inc. | ORGS | partner | Senior Secured Convertible Loan Agreement Holdings | 2022-08-17 | View |
| Orgenesis Inc. | ORGS | customer | Borrower in the Convertible Note Extension Agreement | 2022-07-20 | View |
| Orgenesis Inc. | ORGS | customer | Borrower receiving $3,000,000 convertible loan | 2022-05-23 | View |
| Orgenesis Inc. | ORGS | customer | Borrower receiving $5,000,000 convertible loan | 2022-05-17 | View |
| Orgenesis Inc. | ORGS | customer | Borrower receiving $5,000,000 convertible loan | 2022-04-25 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-03-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-26 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-09-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-25 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-19 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-01 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-06 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-04-22 | Other Events | View | |
| 2025-03-06 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Financ | Agreement Acquisition | View |
| 2025-01-28 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-12-27 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-05 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-11-01 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-10-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-10-17 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2024-08-29 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-08-26 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-08-14 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2024-07-12 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Financ | Agreement Acquisition | View |
| 2024-07-09 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR